X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Pramipexole is a dopamine agonist: it mimics the messenger substance dopamine in the brain and is used in Parkinson's disease and, at a much lower dose, in restless legs syndrome. One of its most important side effects is something hardly anyone mentions of their own accord: impulse control disorders such as gambling addiction, compulsive shopping, binge eating or a greatly increased sex drive. Recognised early, they can usually be brought under control well — provided patients and their families know what to look out for.
See more detail.gif)
Record doses, sleep, mood and anything unusual in one history — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Pramipexole (as pramipexole dihydrochloride monohydrate) |
| ATC code | N04BC05 |
| Drug class | Dopamine agonist without an ergot structure (non-ergot agonist), acting mainly at D2 and D3 receptors |
| Dosage forms | Immediate-release tablets (in Parkinson's usually three times a day), prolonged-release tablets (once a day) |
| Half-life | About 8 hours in younger people, up to about 12 hours in older age; excreted mainly unchanged via the kidneys |
| Maximum daily dose | According to the SmPC, 3.3 mg pramipexole base in Parkinson's (equivalent to 4.5 mg salt), 0.54 mg base in restless legs syndrome (equivalent to 0.75 mg salt) |
| Onset of effect | In Parkinson's, gradually over the weeks of dose titration; in restless legs syndrome often noticeable within a few days |
| Prescription status | Prescription-only medicine |
| Notable feature | Strength is stated either as base or as salt; impulse control disorders and sudden sleep attacks are possible; never stop abruptly |
In Parkinson's disease, the brain lacks the messenger substance dopamine. There are two ways of making up for this: you supply the precursor from which the remaining nerve cells make dopamine themselves — that is levodopa. Or you act directly on the receiving sites (receptors) and mimic dopamine — that is what dopamine agonists such as pramipexole do.¹
Because pramipexole does not depend on conversion in nerve cells and works considerably longer than levodopa, it stimulates the receptors more evenly. That is its strength: fewer fluctuations in effect and fewer excess movements in the first few years. Its weakness: it is less effective than levodopa against the movement symptoms and has more psychological side effects.²
The key to these side effects lies in its receptor preference. Pramipexole acts particularly strongly at the D3 receptors, which are concentrated in the brain's reward system — where motivation, desire and pleasure arise. If this system is stimulated continuously, impulses that would otherwise be kept in check can gain the upper hand. This explains why gambling, shopping or binge eating occur much more often with dopamine agonists than with levodopa.³
In restless legs syndrome (RLS), pramipexole acts on the dopamine system, which is involved there in producing the urge to move — at a fraction of the Parkinson's dose. This article covers both areas of use; the conditions themselves are described in the linked articles.
The figures below describe the approach given in the SmPC.¹ They are not a dosing recommendation — the dose and the pace of adjustment are set by the treating practice.
Pramipexole tablets carry two different numbers: the amount of pure active substance (base) and the amount of the salt in which it is present. The same tablet can therefore be labelled 0.18 mg (base) or 0.25 mg (salt). In Europe the base figure is usual; in other countries and in older documents you will often find the salt figure.¹ When the manufacturer changes, after a hospital stay or with medicines from abroad, this can easily lead to mix-ups. With every new pack, check whether the number matches your medication plan, and ask at the pharmacy if it differs.
A new dose every week? Reminders and your history adapt — and show what is changing.
Many side effects of pramipexole depend on the dose and are therefore rarer and milder in restless legs syndrome than in Parkinson's.¹
This is the core of this article. On dopamine agonists, people can develop behaviours that were previously alien to them — and which they often do not connect with the medicine. The SmPC explicitly lists these impulse control disorders and requires that patients and their families are informed about them and asked about them regularly.¹ In a large study of people with Parkinson's, they occurred much more often in those taking dopamine agonists than in those who were not.³ They also occur in restless legs syndrome, though less often.
| Form | How it can show |
|---|---|
| Pathological gambling | New or sharply increasing gambling, online casinos, sports betting, the lottery in unusual amounts; losses are hidden or people try to "win them back" |
| Compulsive shopping | Frequent, unnecessary purchases, often online and at night; parcels that are hidden away; buying the same item several times |
| Binge eating | Cravings, especially for sweet things, eating at night, rapid weight gain — see food cravings |
| Increased sexual desire | Markedly increased desire, new sexual interests, excessive use of pornography, pressure on a partner |
| Punding and hobbyism | Hours of aimless sorting, taking things apart or repeating the same activity; excessive preoccupation with a hobby |
Impulse control disorders have three features that make them dangerous. First, they are associated with shame: hardly anyone talks about gambling debts or sexual changes without being asked. Second, the link with the medicine is often missing — people experience the behaviour as their own weakness or a change in character, not as a side effect. Third, those affected often do not notice the change themselves, or notice it late; it is their partner or their children who notice first.
Pramipexole is never stopped abruptly. The SmPC describes two risks of stopping suddenly or reducing sharply:¹
That is why pramipexole is reduced step by step according to a plan set by your practice. If a withdrawal syndrome occurs, it may be necessary to slow the reduction or temporarily return to the previous dose. That is not failure but part of a safe approach. General principles are explained in the guide stopping medications.
In restless legs syndrome, pramipexole often works quickly and reliably. The difficulty only shows up over time: augmentation. This means the symptoms get worse under treatment — they start earlier in the day, become stronger, set in more quickly at rest and spread to the arms.¹ The typical but wrong response is to increase the dose, which drives the augmentation further.
Because of this risk, the recommendations have shifted. The American Academy of Sleep Medicine now advises against using dopamine agonists such as pramipexole routinely as standard treatment for restless legs syndrome, and puts more emphasis on correcting iron deficiency and on active ingredients such as gabapentin or pregabalin.⁴ For people who are already well controlled on pramipexole without augmentation, this does not mean they have to switch — but it does mean that the dose and course should be reviewed regularly.
Pramipexole is hardly broken down in the liver at all; it is mostly excreted unchanged via the kidneys. Classic interactions via liver enzymes therefore play hardly any role. What matters most are dopamine antagonists, sedating medicines and substances that slow excretion via the kidneys.¹
| Combination | Consequence | What to do |
|---|---|---|
| Antipsychotics and metoclopramide | Block dopamine — the effect of pramipexole is cancelled out and Parkinson's symptoms get worse | Avoid; for psychosis only selected substances such as quetiapine come into question |
| Sleeping tablets and sedatives, sedating antidepressants | Increased tiredness, more sleep attacks, risk of falls | Only after seeking advice |
| Alcohol | Increases tiredness and the tendency to fall asleep | Hold back; see medications and alcohol |
| Cimetidine, amantadine | Can slow excretion via the kidneys, so the pramipexole level rises | Watch for side effects, have the dose checked by a doctor |
| Levodopa | More excess movements and hallucinations possible | The levodopa dose often needs adjusting |
| Blood pressure lowering medicines | Greater drop in blood pressure on standing up | Check blood pressure while standing |
The most common stumbling block in everyday life is metoclopramide for nausea — a medicine that is often given routinely in emergency departments and after operations. If you take pramipexole, mention it with every new prescription. The interaction check in the brite app flags dopamine antagonists and sedating combinations in your list.
Because pramipexole is excreted almost entirely via the kidneys, its level rises as kidney function declines. The SmPC therefore provides for adjusting the dose and dosing frequency.¹ With chronic kidney disease, or if kidney values worsen in older age, the pramipexole dose should be reviewed. General information in the guide medications for kidney and liver disease.
In older age, hallucinations, confusion and daytime tiredness occur more often with dopamine agonists. The guideline therefore tends to see levodopa as the first choice in older people.² If you already take pramipexole, have your medication reviewed if new memory problems, confusion at night or falls occur — do not stop it on your own.
Experience in pregnancy is limited; according to the SmPC, it should only be taken after a strict weighing of benefits and risks.¹ Pramipexole inhibits the milk-producing hormone prolactin and can suppress milk production; it is therefore usually not used while breastfeeding. For restless legs syndrome, which is more common in pregnancy, other measures come first.
The SmPC recommends having an eye examination if vision problems occur and having your eyes checked at regular intervals.¹ In severe mental illness, especially psychosis, pramipexole is only used with great caution.
Yes, that is possible, and it is important that you raise it. Pathological gambling is a known side effect of dopamine agonists such as pramipexole. The change is not a character flaw and is usually not deliberately hidden — many people do not connect it with the medicine at all. Make an appointment at the neurology practice soon, and ideally go along too. Do not stop the medicine yourself, but in the meantime protect your finances, for example with card limits and a gambling self-exclusion.
Perhaps, but not necessarily. Binge eating, especially with cravings for sweet things, is one of the impulse control disorders that occur with dopamine agonists. If the change began after pramipexole was started or increased, that is an important clue for your practice. Weight gain on pramipexole should therefore always be raised — even if it feels embarrassing.
That may be a dopamine agonist withdrawal syndrome. It shows up more in the mind than in the body: anxiety, panic, low mood, exhaustion, sometimes pain and sweating. Levodopa hardly helps against it. Raise the symptoms quickly; the reduction is often slowed down. If you have suicidal thoughts or unbearable anxiety, you need help immediately — via your practice, the out-of-hours medical service on 116 117 or 112.
Please do not do this on your own. An earlier start, stronger symptoms or spreading to the arms point to augmentation — a typical long-term consequence of dopaminergic RLS medicines. A higher dose usually makes it worse. Your practice will check your iron levels and consider whether a change of treatment makes sense. Until your appointment, note every day when the symptoms start.
The interaction check shows dopamine antagonists and increased tiredness in your list.
A dose plan, a sleep and mood history and an interaction check in one place. Free.
Create medication plan